3 ms·

I think the difference is releasing self driving provides the data Tesla needs to improve it. Releasing a half baked drug doesn't help the pharma company improv

I think the difference is releasing self driving provides the data Tesla needs to improve it. Releasing a half baked drug doesn't help the pharma company improve it. If you're asking whether that would be awesome if it lead to pharmaceutical innovations I think it would.

flutas 5y ago
> I think the difference is releasing self driving provides the data Tesla needs to improve it. Releasing a half baked drug doesn't help the pharma company improve it. The pharma company could see results (self-driving car data) and figure out what caused the issues (details of the deaths in pharma, accidents in Tesla) and use that to make the next beta version. I don't really see how that isn't an apt analogy. It's called clinical trials for pharma the key point being it's opt in and doesn't affect anyone around the subject, unlike Tesla's autopilot beta.
AlexandrB 5y ago
> Releasing a half baked drug doesn't help the pharma company improve it. Sure it does. It identifies cases where the drug may have unexpected side effects so either the chemistry, dosage, or expected risk factors can be refined.